http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022157473-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f89c8c2c34a9c327d688f5b93c475508 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afccd56726bb8fd92de04cd8e33714fa |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6827 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6869 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-00 |
| filingDate | 2021-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0db23b28c53f016d87f2d3b1f63b3a08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a5af5972a3f10e4dc6e51f9ed2ca50f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09509290e6e67f8f4bd9ecf71aee8f99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f50fa941c8525e5922ffef8fc23572a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3ba61919ab0bcf1cb80b271f9cd0e01 |
| publicationDate | 2022-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2022157473-A |
| titleOfInvention | A method for determining the presence or absence of a genetic predisposition to exhibit high serum uric acid levels after menopause, a method for detecting a single nucleotide polymorphism (SNP) allele, a composition, and a kit |
| abstract | An object of the present invention is to provide a method for knowing the risk of developing hyperuricemia in adult women. A method for determining the presence or absence of a genetic predisposition to exhibit high serum uric acid levels after menopause, the method comprising the steps of: Genetic predisposition to exhibit high postmenopausal serum uric acid levels in an adult female subject when at least one of the following single nucleotide polymorphisms (SNPs) (a) to (c) in a nucleic acid derived from the subject is a risk allele: and determining that there is no genetic predisposition to exhibit a high serum uric acid level after menopause when none of the single nucleotide polymorphisms (SNPs) is a risk allele, The above-mentioned risk alleles are homozygous alleles that show a higher average serum uric acid level than the other homozygous type when comparing the average serum uric acid levels in populations having each of the two homozygous types. and The method, wherein the elevated serum uric acid level and the elevated serum uric acid level are a serum uric acid level of 7 mg/dL or more. (a) rs1351879 on human chromosome 2 (b) rs4430896 on human chromosome 2 (c) rs117377116 on human chromosome 12 [Selection figure] None |
| priorityDate | 2021-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.